Maple Capital Management, Inc. - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 89 filers reported holding ENZO BIOCHEM INC in Q4 2015. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Maple Capital Management, Inc. ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q1 2017$117,000
+20.6%
14,0000.0%0.04%
+16.7%
Q4 2016$97,000
+36.6%
14,0000.0%0.03%
+30.4%
Q3 2016$71,000
-15.5%
14,0000.0%0.02%
-25.8%
Q2 2016$84,000
+31.2%
14,0000.0%0.03%
+29.2%
Q1 2016$64,000
+1.6%
14,0000.0%0.02%
+9.1%
Q4 2015$63,000
+43.2%
14,0000.0%0.02%
+37.5%
Q3 2015$44,000
+4.8%
14,0000.0%0.02%
+14.3%
Q2 2015$42,000
+2.4%
14,0000.0%0.01%0.0%
Q1 2015$41,000
-33.9%
14,0000.0%0.01%
-36.4%
Q4 2014$62,00014,0000.02%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2015
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,886,771$10,219,00013.54%
HARBERT FUND ADVISORS, INC. 5,175,913$18,323,0006.51%
Evermore Global Advisors, LLC 1,730,607$6,126,0005.39%
VIEX Capital Advisors, LLC 1,510,401$5,347,0003.24%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$90,0000.05%
RBF Capital, LLC 250,359$886,0000.05%
CORRADO ADVISORS, LLC 19,366$69,0000.04%
Cutter & CO Brokerage, Inc. 27,827$99,0000.02%
Ergoteles LLC 177,048$627,0000.02%
FULLER & THALER ASSET MANAGEMENT, INC. 941,760$3,334,0000.02%
View complete list of ENZO BIOCHEM INC shareholders